Stockreport

Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF Company to host conference call and webcast today at 8:30 a.m. ESTCARMIEL, Israel, Nov. 14, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a b [Read more]